Dietary DASH score | Quartile1 < 20 | Quartile2 21–24 | Quartile3 25–28 | Quartile4 > 29 | P for trend |
---|---|---|---|---|---|
Colorectal cancer | |||||
 Women | |||||
  Case (control) | 19(14) | 23(23) | 16(28) | 5(42) |  |
  Crude OR (95% CI) | 1.00 | 0.73(0.29–1.81) | 0.42(0.16–1.06) | 0.08(0.02–0.27) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.76(0.29–1.97) | 0.42(0.16–1.11) | 0.07(0.02–0.24) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.89(0.31–2.54) | 0.42(0.14–1.24) | 0.07(0.02–0.26) | < 0.001 |
 Men | |||||
  Case (control) | 37(22) | 22(26) | 5(40) | 2(45) |  |
  Crude OR (95% CI) | 1.00 | 0.50(0.23–1.09) | 0.07(0.02–0.21) | 0.02(0.00–0.12) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.47(0.21–1.06) | 0.06(0.02–0.18) | 0.02(0.00–0.10) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.63(0.26–1.48) | 0.07(0.02–0.24) | 0.02(0.00–0.13) | < 0.001 |
 Pooled | |||||
  Case (control) | 56(36) | 45(49) | 21(68) | 7(87) |  |
  Crude OR (95% CI) | 1.00 | 0.59(0.33–1.05) | 0.19 (0.10–0.37) | 0.05(0.02–0.12) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.57(0.31–1.04) | 0.17(0.09–0.34) | 0.04 (0.01–0.10) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.69(0.36–1.31) | 0.22(0.11–0.44) | 0.04(0.01–0.11) | < 0.001 |
Adenoma | |||||
 Women | |||||
  Case (control) | 25(14) | 20(23) | 18(28) | 8(42) |  |
  Crude OR (95% CI) | 1.00 | 0.58(0.28–1.21) | 0.38(0.18–0.79) | 0.13(0.05–0.32) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.57(0.27–1.19) | 0.32 (0.15–0.68) | 0.04(0.04–0.27) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.42(0.16–1.12) | 0.25(0.09–0.69) | 0.06 (0.02–0.20) | < 0.001 |
 Men | |||||
  Case (control) | 22(22) | 17(26) | 14(40) | 6(45) |  |
  Crude OR (95% CI) | 1.00 | 0.56(0.26–1.22) | 0.33(0.15–0.73) | 0.11(0.04–0.30) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.65(0.27–1.53) | 0.35(0.15–0.81) | 0.13(0.04–0.37) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.68(0.26–1.72) | 0.30 (0.11–0.80) | 0.14(0.04–0.44) | < 0.001 |
 Pooled | |||||
  Case (control) | 47(36) | 37(49) | 32(68) | 14(87) |  |
  Crude OR (95% CI) | 1.00 | 0.57(0.37–1.06) | 0.36(0.19–0.66) | 0.12 (0.06–0.25) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.57(0.31–1.07) | 0.30 (0.16–0.57) | 0.10(0.04–0.21) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.60(0.31–1.15) | 0.31 (0.16–0.61) | 0.10(0.04–0.22) | < 0.001 |
Colorectal cancer plus Adenoma | |||||
 Women | |||||
  Case (control) | 44(14) | 43(23) | 34(28) | 13(42) | < 0.001 |
  Crude OR (95% CI) | 1.00 | 0.59(0.27–1.30) | 0.38(0.17–0.84) | 0.09(0.04–0.23) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.55(0.24–1.24) | 0.34(0.15–0.77) | 0.08(0.03–0.20) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.59(0.25–1.39) | 0.35(0.15–0.83) | 0.07 (0.02–0.18) |  |
 Men | |||||
  Case (control) | 59(22) | 39(26) | 19(40) | 8(45) | < 0.001 |
  Crude OR (95% CI) | 1.00 | 0.55(0.27–1.12) | 0.17(0.08–0.36) | 0.06(0.02–0.16) | 0.03 |
  Adjusted OR* (95% CI) | 1.00 | 0.55(0.27–1.12) | 0.15(0.07–0.33) | 0.05(0.02–0.14) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.64(0.30–1.35) | 0.16 (0.07–0.37) | 0.06(0.02–0.16) |  |
 Pooled | |||||
  Case (control) | 103(36) | 82(49) | 53(68) | 21(87) | < 0.001 |
  Crude OR (95% CI) | 1.00 | 0.58(0.34–0.98) | 0.27(0.16–0.45) | 0.08 (0.04–0.15) | < 0.001 |
  Adjusted OR* (95% CI) | 1.00 | 0.56(0.33–0.95) | 0.24 (0.14–0.41) | 0.07(0.03–0.13) | < 0.001 |
  Adjusted OR**(95% CI) | 1.00 | 0.64(0.37–1.10) | 0.26 (0.10–0.47) | 0.07(0.03–0.14) |  |